Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Landmark Supreme Court Decision Supports States’ Rights to Regulate Pharmacy Benefit Managers

Keri Losavio  |  Issue: January 2021  |  December 16, 2020

Photo: Insta_Photos; Erik Cox Photography/Shutterstock.com

On Dec. 10, the Supreme Court of the United States of America (SCOTUS) issued a landmark decision in Rutledge, Attorney General of Arkansas, v. Pharmaceutical Care Management Association. In an 8–0 decision, the justices agreed that states have the right to impose regulations on pharmacy benefit managers (PBMs), companies that manage prescription drug benefits on behalf of health insurers, Medicare Part D drug plans, large employers and other payers. Justice Amy Coney Barrett took no part in the consideration or decision of this case.

The ACR and the Alliance for Transparent and Affordable Prescriptions (ATAP), a coalition of patient and provider groups, have long argued that too few restrictions have been placed on PBM transparency and requirements for PBMs to pass negotiated savings on to payers and patients are needed. This decision from SCOTUS sets the stage for states to impose further regulations to ensure patients and providers have necessary protections and the profit motives of PBMs are clear to all.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The ACR has played an active role in these issues in Arkansas and other states as the states crafted new regulations involving PBMs. The ACR and its partners in the ATAP coalition also filed an amicus brief in the Rutledge case arguing in part that PBMs are engaged in abusive practices with serious practical and policy consequences, including upward pressure on prescription drug pricing.

“The Supreme Court is now amplifying the light we are shining on the previously hidden profit motives of the PBM industry,” said Angus Worthing, MD, a practicing rheumatologist with Arthritis & Rheumatism Associates PC, Washington, D.C., a clinical assistant professor of medicine at Georgetown University, and past chair of the ACR’s Government Affairs Committee. “With this decision and other actions in Washington and various states, patients, physicians and policy makers now have the power to effect meaningful change.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Share: 

Filed under:American College of RheumatologyPractice Support Tagged with:Alliance for Transparent & Affordable Prescriptions (ATAP)pharmacy benefit managers (PBMs)U.S. Supreme Court

Related Articles

    The Impact of U.S. Supreme Court Decisions on Medical Affairs, Healthcare Policy

    October 11, 2016

    As America’s capital, Washington, D.C., maintains an outsized influence in our daily lives. Despite having a meager sliver of the New York City population, the daily political transactions that transpire in the District of Columbia impact our lives. The comings and goings in the corridors of Congress are likely to have a greater impact on us…

    Arkansas PBM Bill: A Step in the Right Direction

    April 4, 2018

    During a three-day special legislative session in March, Arkansas Governor Asa Hutchinson (R) signed into law the first bill in the U.S. intended to address a lack of transparency among pharmacy benefit managers (PBMs) and their role in the high cost of prescription drugs.1 The bill, H.B. 1010: Arkansas Pharmacy Benefits Manager Licensure Act, will…

    Florida Law Puts Drug Pricing by Pharmacy Benefit Managers Under a Microscope Once Again

    August 8, 2022

    As of July 1, a Florida bill increases oversight of pharmacy benefit managers and offers some protection for pharmacies. However, the legislation has limited effects on patients and providers, highlighting the need for additional reform.

    Rheumatologists Air Frustrations with Pharmacy Benefit Managers at Annual Meeting

    January 19, 2018

    SAN DIEGO—Pharmacy benefit managers (PBMs) and their impact on drug prices and access to high-cost medications by the patients rheumatologists treat was a major theme at the 2017 ACR/ARHP Annual Meeting Nov. 3–8. In one session, industry experts tried to clarify the role for prior authorizations and drug formulary policies and explored ways to constructively…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences